For the Inventor, By the Inventor

Enter assignee name

Leuven, Bulgaria

Leuven Research & Development Vzw

USPTO Granted Patents = 26

Forward Citations = 283

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Paul N Holvoet (9 out of 10 patents)

Desire J Collen (9 out of 11 patents)

Désiré José Collen (3 out of 4 patents)

4. Désiré J Collen (2 out of 3 patents)

5. Adrien Edgard Cremers (2 out of 2 patents)

6. Andre Petrus Maes (2 out of 2 patents)

7. Lucas J Delaey (2 out of 2 patents)

8. Jean-Marie Saint-Remy (1 out of 40 patents)

9. Marc G Jacquemin (1 out of 13 patents)

10. Desire Jose Collen (1 out of 1 patent)

11. Désiré José Collen (1 out of 2 patents)

12. Désire José Collen (1 out of 1 patent)

13. Désiré José Collen (1 out of 1 patent)

14. Désiré J Collen (1 out of 1 patent)

15. Jozef Leonia Pleysier (1 out of 1 patent)

26 patents: Sort by Forward Citations

1. 7604952 - Detection and determination of the stages of coronary artery disease (2009-10-20),

2. 7579159 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2009-08-25),

3. 7390627 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2008-06-24),

4. 7378250 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2008-05-27),

5. 7229776 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2007-06-12),

6. 7229775 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2007-06-12),

7. 7166469 - Detection and determination of the stages of coronary artery disease (2007-01-23),

8. 6902733 - Staphylokinase derivatives with polyethyleneglycol (2005-06-07),

9. 6727102 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2004-04-27),

10. 6602509 - Compound and method for the prevention and/or the treatment of allergy (2003-08-05),

11. 6309888 - Detection and determination of the stages of coronary artery disease (2001-10-30),

12. 5951980 - Identification, production and use of new staphylokinase derivatives (1999-09-14),

13. 5695754 - Staphylokinase derivatives (1997-12-09),

14. 5174994 - Pharmaceutical composition having thrombolytic activity (1992-12-29),

15. 4752603 - Plasminogen activator and pharmaceutical composition having thrombolytic (1988-06-21),

Leuven Research & Development Vzw is a non-profit organization based in Leuven, Belgium. We specialize in promoting and supporting scientific research and development activities for various industries. Our mission is to foster collaboration between academic institutions, industry partners, and government agencies to drive innovation and technological advancements. Through our extensive network, we provide funding opportunities, project management, and access to state-of-the-art research facilities. Visit our website to learn more about our programs, ongoing projects, and the impact of our research contributions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

26 Patents

#1 in Leuven

#1 in Bulgaria

#24,092 in the World

Leuven, Bulgaria

Leuven Research & Development Vzw

Forward Citations = 283

24 inventors:

Paul N Holvoet (9 out of 10 patents)

Desire J Collen (9 out of 11 patents)

Désiré José Collen (3 out of 4 patents)

4. Désiré J Collen (2 out of 3 patents)

5. Adrien Edgard Cremers (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…